Dr Ian Campbell is an experienced executive in the life sciences. Ian joined Innovate UK in October 2016 as Director for Health and Life Sciences. Prior to that, he most recently served as Chief Executive of Arquer Diagnostics, a company developing and commercialising immunoassay tests for cancers of the urinogenitary tract. He was also Chief Executive of Imperial College spin-out company Molecular Vision, developing a disposable, quantitative point-of-care diagnostic platform, before the company was acquired by Abingdon Health in 2012. Ian has also served as Commercial Director with Bespak Europe. Ian has a strong scientific background, gaining his PhD at the University of Glasgow.